Development of purified glycogen derivatives as siRNA nanovectors

Int J Pharm. 2021 Oct 25:608:121128. doi: 10.1016/j.ijpharm.2021.121128. Epub 2021 Sep 21.

Abstract

Purified Glycogen (PG) is a highly hyper branched carbohydrate, characterized by high water solubility and very moderate increase in viscosity. The dendrimeric structure of PG, appropriately functionalized, makes it an alternative to current synthetic gene delivery agents. The present study explores the preparation of purified glycogen polycationic derivatives (PGPDs), developed and characterized starting from a single step reaction between PG and N,N-dialkylamino alkyl halides. Subsequently PGPDs were used for the complexation of a model siRNA nucleic acid, a transfection reagent siRNA and a fluorescein-labelled dsRNA oligomer. PGPDs-siRNA complexes were fully characterized by agarose gel electrophoresis and their efficacy was assessed by both confocal microscopy and transfection assays on breast and renal cancer cells. Results proved that PGPDs-siRNA complexes were efficient and not cytotoxic, maintaining their spherical and dendrimeric structure and, particularly, were able to effectively transfect the target cells by releasing the siRNA.

Keywords: Cationic polymers; Dendrimers; Gene silencing; Glycogen; Nanocarriers; siRNA; siRNA delivery.

MeSH terms

  • Gene Transfer Techniques*
  • Genetic Therapy
  • Glycogen*
  • RNA, Small Interfering
  • Transfection

Substances

  • RNA, Small Interfering
  • Glycogen